A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients with Systemic Lupus Erythematosus (SLE)

Project: Research

Project Details

StatusActive
Effective start/end date20/02/20 → 19/02/25

Keywords

  • Clinical trial
  • phase 3 study
  • lupus
  • SLE
  • systemic lupus erythematosus (SLE)
  • treatment safety